Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Marimed (MRMD) Short-term Investments (2019 - 2023)

Marimed (MRMD) has disclosed Short-term Investments for 10 consecutive years, with $88000.0 as the latest value for Q4 2023.

  • Quarterly Short-term Investments fell 28.46% to $88000.0 in Q4 2023 from the year-ago period, while the trailing twelve-month figure was $88000.0 through Dec 2023, down 28.46% year-over-year, with the annual reading at $88000.0 for FY2023, 28.46% down from the prior year.
  • Short-term Investments for Q4 2023 was $88000.0 at Marimed, down from $161000.0 in the prior quarter.
  • The five-year high for Short-term Investments was $1.4 million in Q4 2019, with the low at $88000.0 in Q4 2023.
  • Average Short-term Investments over 5 years is $655710.1, with a median of $643571.0 recorded in 2020.
  • The sharpest move saw Short-term Investments surged 72.15% in 2021, then plummeted 91.7% in 2023.
  • Over 5 years, Short-term Investments stood at $1.4 million in 2019, then decreased by 6.35% to $1.4 million in 2020, then plummeted by 81.51% to $251000.0 in 2021, then tumbled by 51.0% to $123000.0 in 2022, then fell by 28.46% to $88000.0 in 2023.
  • According to Business Quant data, Short-term Investments over the past three periods came in at $88000.0, $161000.0, and $102000.0 for Q4 2023, Q3 2023, and Q2 2023 respectively.